OBERDORF SYNTHES PRODUKTIONS GMBH

Manufacturer adverse-event records for OBERDORF SYNTHES PRODUKTIONS GMBH come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.

FDA MAUDE device safety record · 2012–2022 · mid-book · typical Death-code · injury-heavy

Injury-mix signature

OBERDORF SYNTHES PRODUKTIONS GMBH leans injury-heavy in event_type mix

Injury-coded event_type share is 67.9% (injury-heavy tercile) beside 0.12% Death-coded (typical). Volume band: mid.

What the Injury-mix reading shows for OBERDORF SYNTHES PRODUKTIONS GMBH

The standout signal for OBERDORF SYNTHES PRODUKTIONS GMBH is Injury-mix: 67.9% Injury-coded (injury-heavy) beside 0.12% Death-coded, on a mid-book footprint.

Mid-pack volume still shows a clear device fingerprint; the table below is the actionable layer for OBERDORF SYNTHES PRODUKTIONS GMBH. Event_type Death/Injury codes differ from patient-outcome rows - see methodology.

Reports span 20 device types, led in this extract by Injury at 11,455 (67.9% of event_type total). Peak single-year volume reaches 7,269 reports across 6 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.

16,864
Total Reports
20
Event-type Death
11,455
Injury Reports
20
Device Types

Event Types

Injury 11,455 (67.9%)
Malfunction 5,389 (32.0%)
Death 20 (0.1%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

Required Intervention 11,336 (67.2%)
5,499 (32.6%)
Death 20 (0.1%)
R 13 (0.1%)
Life Threatening 5 (0.0%)
Hospitalization 3 (0.0%)
Congenital Anomaly 1 (0.0%)

Yearly Trend

12
2012: 3
17
2017: 155
18
2018: 3,939
19
2019: 7,269
20
2020: 5,497
22
2022: 1